Cepham's new Luteye ingredient combines lutein and zeaxanthin with extra virgin olive oil enriched with oleocanthal.
Cepham (Somerset, NJ) has announced the launch of Luteye, which is a branded ingredient that combines lutein and zeaxanthin with extra virgin olive oil enriched with oleocanthal.
“By the time the symptoms of eye aging become apparent, it is often too late to take corrective action,” said Anand Swaroop, founder and president of Cepham, in a press release. “This is why our research for eye health is centered around cellular senescence.”
Cepham goes on to explain that cellular senescence is the process by which cells age. Eventually these cells will stop dividing, but don’t die, rather building up in tissues throughout the body. This process, says Cepham, is connected to the progression of age-related macular degeneration, and its related symptoms.
“We've thoroughly studied oleocanthal to understand its potential in combating aging effects on the eyes caused by cellular senescence, such as short telomeres, DNA damage response, mitochondrial dysfunction, and epigenetically induced senescence,” said Swaroop. “When combined with proven vision enhancing nutrients like lutein and zeaxanthin, oleocanthal shows potential to powerfully protect the eyes from aging.”
Instead of using carrier oils like soy, safflower or canola that contain chemical stabilizers and surfactants, like other eye health products, Cephams says that its Luteye harnesses the antioxidant properties of oleocanthal, a natural stabilizer, and extra virgin olive oil to eliminate the need for chemical surfactants. This makes the product “clean-label.”
Survey finds a lack of enthusiasm about AI technology among food and beverage consumers
December 12th 2024The survey, commissioned by Ingredient Communications and conducted by SurveyGoo, found that 83% of respondent agreed that companies should declare on product labels when a product has been designed or manufactured with the assistance of AI technology.
Kelker Pharma to launch nutritional support system for GLP-1 medication users that features TriBsyn
December 11th 2024B&D Nutritional Ingredients Inc., an exclusive distribution partner of CarnoSyn Brands and Natural Alternatives International Inc., announced that its customer, Kelker Pharma, will be launching the “first science-backed nutritional support system” for GLP-1 medication users, called Nutrilinq Genesis.